May 28, 2018 [News Release]
GlyTech Secures Approx. 1,000 Million JPY in Series A Financing From Leading Japanese Venture Capital Firms
GlyTech, Inc. has raised 1,000 million JPY in Series A financing from five leading venture capital firms: Nippon Shokubai Co., Fushimi Pharmaceutical Co., SBI Investment Co., Osaka University Venture Capital Co., and MIAT S.p.A.
Apr 17, 2018 [News Release]
GlyTech, Inc. to Deliver a Lecture at a Seminar Held by Johokiko Co.
GlyTech, Inc. is scheduled to deliver a lecture at a seminar on "Glycan Control for Biopharmaceuticals, and Analysis & Evaluation of Glycan Heterogeneity" to be held by Johokiko Co. in Tokyo on April 17th 2018. The lecture will discuss the development of next generation biopharmaceuticals and important considerations for the management of glycans of generic drugs.
Mar 29, 2018 [News Release]
An interview with GlyTech's CEO, Mr. Hiroaki Asai, and an article about GlyTech, Inc. have been published on RikeLab, a website managed by Temp R&D.
"RikeLab - A research institute for ideal ways of working in science" is an information portal site managed by Temp R&D (Persol Tempstaff Co.) that focuses on ideal ways of working for people with scientific knowledge and expertise.
Mar 27, 2018 [News Release]
GlyTech, Inc. to Present at the 138th Annual Meeting of the Pharmaceutical Society of Japan (Kanazawa)
GlyTech, Inc. (CEO: Mr. Hiroaki Asai) is scheduled to make oral and poster presentations at the 138th Annual Meeting of the Pharmaceutical Society of Japan (Kanazawa) in Kanazawa on March 27th 2018.
Feb 16, 2018 [News Release]
GlyTech, Inc. to Exhibit at Kansai Bio-Business Matching 2018
GlyTech, Inc. is scheduled to exhibit at Kansai Bio-Business Matching 2018, which is to be held by the Kinki Bio-industry Development Organization at the Senri Hankyu Hotel on February 16th 2018.
Feb 4, 2018 [News Release]
GlyTech, Inc. to Take Part in Regional Contribution Project "Dispatch of Life Science Companies to the Boston Area"
GlyTech, Inc. has been selected to take part in JETRO's Regional Contribution Project "Dispatch of Life Science Companies to the Boston Area" from February 4-11, 2018, and is scheduled to make a presentation at the Kyoto Life Science Venture Networking Seminar in Boston.